Effects of Micronutrient (Chromium) Supplementation on Diabetes
Status: | Completed |
---|---|
Conditions: | Diabetes |
Therapuetic Areas: | Endocrinology |
Healthy: | No |
Age Range: | 8 - 21 |
Updated: | 4/2/2016 |
Start Date: | August 2007 |
End Date: | September 2013 |
Contact: | Sushil K Jain, Ph.D. |
Email: | sjain@lsuhsc.edu |
Phone: | 318-675-6086 |
Ketosis, Vascular Inflammation, and Its Therapy (Chromium Supplementation) in Diabetic Patients
6-8% of USA population has diabetes. Intensive blood glucose control dramatically reduces
the devastating complications that result from poorly controlled diabetes. However, for many
patients, achievement of tight glucose control is difficult with current regimens. Trivalent
chromium, the form found in foods and dietary supplements, is believed to be safe. Our
preliminary studies have reported that chromium supplementation inhibits the increase in
pro-inflammatory cytokines (tumor necrosis factor-alpha and interleukin-6; TNF-alpha and
IL-6) secretion levels caused by high glucose levels in cultured monocytic cells. Similarly,
animal studies have shown that chromium niacinate supplementation lowered blood levels of
glycemia and pro-inflammatory cytokines in streptozotocin-treated diabetic rats. Cytokines
are proteins that are secreted by monocytes and other cells in response to various stimuli,
such as infection. Some of the cytokines are known to regulate insulin sensitivity and
elevated level of these cytokines in blood may accelerate clogging of arteries. Thus,
chromium supplementation may increase insulin sensitivity and glycemic control in diabetic
patients, and may prevent the development of cardiovascular disease in diabetic patients.
Given the enormous public health cost of diabetes, the prospect of being able to use a
relatively low-cost dietary supplement, such as chromium, as an adjuvant therapy to help in
achieving normal blood glucose level merits further study.
We will examine the effects of placebo and chromium niacinate supplementation on the fasting
glucose, cholesterol, triglycerides, and markers of vascular disease in blood of diabetic
patients. We will determine these above parameters at baseline and after the 1, 2 and 3
months of supplementation in diabetic patients. The long-term objective is to explore the
efficacy of chromium as an adjuvant treatment for better glycemic control, prevent the
development of cardiovascular disease (CVD), and improve the life expectancy in diabetic
population.
Chromium supplements are widely used by the public and are available in many stores, such as
Wal-mart, Walgreens, and many other food and drug stores. Chromium is an essential trace
metal and micronutrient present in wide variety of vegetables. Niacin is a vitamin B6, an
essential vitamin for our body. This study plans to use chromium niacinate, a complex of
chromium and niacin. Chromium niacinate is considered a nutrient.
the devastating complications that result from poorly controlled diabetes. However, for many
patients, achievement of tight glucose control is difficult with current regimens. Trivalent
chromium, the form found in foods and dietary supplements, is believed to be safe. Our
preliminary studies have reported that chromium supplementation inhibits the increase in
pro-inflammatory cytokines (tumor necrosis factor-alpha and interleukin-6; TNF-alpha and
IL-6) secretion levels caused by high glucose levels in cultured monocytic cells. Similarly,
animal studies have shown that chromium niacinate supplementation lowered blood levels of
glycemia and pro-inflammatory cytokines in streptozotocin-treated diabetic rats. Cytokines
are proteins that are secreted by monocytes and other cells in response to various stimuli,
such as infection. Some of the cytokines are known to regulate insulin sensitivity and
elevated level of these cytokines in blood may accelerate clogging of arteries. Thus,
chromium supplementation may increase insulin sensitivity and glycemic control in diabetic
patients, and may prevent the development of cardiovascular disease in diabetic patients.
Given the enormous public health cost of diabetes, the prospect of being able to use a
relatively low-cost dietary supplement, such as chromium, as an adjuvant therapy to help in
achieving normal blood glucose level merits further study.
We will examine the effects of placebo and chromium niacinate supplementation on the fasting
glucose, cholesterol, triglycerides, and markers of vascular disease in blood of diabetic
patients. We will determine these above parameters at baseline and after the 1, 2 and 3
months of supplementation in diabetic patients. The long-term objective is to explore the
efficacy of chromium as an adjuvant treatment for better glycemic control, prevent the
development of cardiovascular disease (CVD), and improve the life expectancy in diabetic
population.
Chromium supplements are widely used by the public and are available in many stores, such as
Wal-mart, Walgreens, and many other food and drug stores. Chromium is an essential trace
metal and micronutrient present in wide variety of vegetables. Niacin is a vitamin B6, an
essential vitamin for our body. This study plans to use chromium niacinate, a complex of
chromium and niacin. Chromium niacinate is considered a nutrient.
Inclusion Criteria:
- Clinical diagnosis of Type 1 diabetes mellitus
- Participants between the ages of 8 and 21
Exclusion Criteria:
- Subjects with sickle cell disease, renal or liver disease
- Serum positive pregnancy test or breastfeeding
- Participants unwilling/unable to take supplements in pill form
- Participants taking prescription medication or supplements
We found this trial at
1
site
Click here to add this to my saved trials